L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib. (2018)

First Author: Callegari D
Attributed to:  Sustainable RSE Careers for Sustainable Software Development funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c7sc04761d

PubMed Identifier: 29732058

Publication URI: http://europepmc.org/abstract/MED/29732058

Type: Journal Article/Review

Volume: 9

Parent Publication: Chemical science

Issue: 10

ISSN: 2041-6520